News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,628 Results
Type
Article (40796)
Company Profile (297)
Press Release (668535)
Multimedia
Podcasts (75)
Webinars (12)
Section
Business (207337)
Career Advice (2072)
Deals (35971)
Drug Delivery (100)
Drug Development (82453)
Employer Resources (176)
FDA (16271)
Job Trends (15185)
News (350583)
Policy (32929)
Tag
Academia (2580)
Accelerated approval (5)
Adcomms (20)
Allergies (87)
Alliances (50378)
ALS (90)
Alzheimer's disease (1404)
Antibody-drug conjugate (ADC) (133)
Approvals (16269)
Artificial intelligence (260)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11763)
BIOSECURE Act (21)
Biosimilars (108)
Biotechnology (212)
Bladder cancer (79)
Brain cancer (28)
Breast cancer (284)
Cancer (2293)
Cardiovascular disease (181)
Career advice (1729)
Career pathing (33)
CAR-T (153)
Cell therapy (434)
Cervical cancer (19)
Clinical research (67111)
Collaboration (853)
Company closure (1)
Compensation (556)
Complete response letters (21)
COVID-19 (2616)
CRISPR (40)
C-suite (251)
Cystic fibrosis (101)
Data (2247)
Decentralized trials (2)
Denatured (26)
Depression (47)
Diabetes (273)
Diagnostics (6396)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (120)
Drug pricing (103)
Drug shortages (25)
Duchenne muscular dystrophy (95)
Earnings (87745)
Editorial (43)
Employer branding (23)
Employer resources (150)
Events (115014)
Executive appointments (746)
FDA (17564)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (757)
Gene editing (107)
Generative AI (20)
Gene therapy (312)
GLP-1 (744)
Government (4467)
Grass and pollen (5)
Guidances (81)
Healthcare (18914)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (118)
Indications (30)
Infectious disease (2758)
Inflammatory bowel disease (143)
Inflation Reduction Act (9)
Influenza (51)
Intellectual property (97)
Interviews (328)
IPO (16777)
IRA (41)
Job creations (3842)
Job search strategy (1469)
Kidney cancer (10)
Labor market (38)
Layoffs (487)
Leadership (22)
Legal (7976)
Liver cancer (76)
Lung cancer (322)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (312)
MASH (72)
Medical device (13412)
Medtech (13417)
Mergers & acquisitions (19753)
Metabolic disorders (709)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (92)
Neuropsychiatric disorders (29)
Neuroscience (1953)
NextGen: Class of 2025 (6577)
Non-profit (4500)
Now hiring (40)
Obesity (377)
Opinion (222)
Ovarian cancer (77)
Pain (90)
Pancreatic cancer (86)
Parkinson's disease (150)
Partnered (21)
Patents (240)
Patient recruitment (113)
Peanut (46)
People (58212)
Pharmaceutical (76)
Pharmacy benefit managers (19)
Phase I (20955)
Phase II (29604)
Phase III (21943)
Pipeline (1235)
Policy (151)
Postmarket research (2575)
Preclinical (8905)
Press Release (64)
Prostate cancer (108)
Psychedelics (31)
Radiopharmaceuticals (256)
Rare diseases (380)
Real estate (6087)
Recruiting (67)
Regulatory (22594)
Reports (46)
Research institute (2346)
Resumes & cover letters (354)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (71)
Series A (130)
Series B (86)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (31)
Startups (3666)
State (2)
Stomach cancer (13)
Supply chain (70)
Tariffs (44)
The Weekly (47)
Vaccines (709)
Venture capitalists (42)
Weight loss (246)
Women's health (38)
Worklife (20)
Date
Today (194)
Last 7 days (834)
Last 30 days (2742)
Last 365 days (33228)
2025 (11134)
2024 (35753)
2023 (40683)
2022 (51812)
2021 (56358)
2020 (54577)
2019 (47018)
2018 (35412)
2017 (32716)
2016 (32119)
2015 (38168)
2014 (32052)
2013 (26961)
2012 (29102)
2011 (29750)
2010 (27754)
Location
Africa (742)
Alabama (58)
Alaska (7)
Arizona (234)
Arkansas (14)
Asia (39847)
Australia (6331)
California (6233)
Canada (2039)
China (548)
Colorado (270)
Connecticut (278)
Delaware (152)
Europe (84655)
Florida (930)
Georgia (207)
Idaho (57)
Illinois (544)
India (25)
Indiana (315)
Iowa (11)
Japan (166)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (913)
Massachusetts (4674)
Michigan (220)
Minnesota (397)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (64)
New Hampshire (63)
New Jersey (1762)
New Mexico (29)
New York (1775)
North Carolina (1030)
North Dakota (8)
Northern California (2721)
Ohio (205)
Oklahoma (14)
Oregon (35)
Pennsylvania (1391)
Puerto Rico (13)
Rhode Island (33)
South America (1121)
South Carolina (23)
South Dakota (1)
Southern California (2344)
Tennessee (102)
Texas (930)
United States (23590)
Utah (184)
Virginia (150)
Washington D.C. (64)
Washington State (564)
West Virginia (3)
Wisconsin (56)
709,628 Results for "shanghai zhimeng biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
Zhimeng Biopharma CB03 Received Orphan Drug Designation from the US FDA - A Potassium Ion Channel Opener for Amyotrophic Lateral Sclerosis
Shanghai Zhimeng Biopharma, Inc. (“Zhimeng”), announced that one of its innovative small-molecule KCNQ2/3 selective opener compounds (CB03), developed for the treatment of amyotrophic lateral sclerosis (ALS), received orphan drug designation (ODD) from US FDA.
October 20, 2023
·
3 min read
Press Releases
Alligator Bioscience Announces Initiation of HLX22 Phase 2 Trial in Breast Cancer by Shanghai Henlius Biotech, Inc.
April 23, 2025
·
1 min read
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
May 1, 2025
·
1 min read
·
Angela Gabriel
Layoffs
Q1 Biopharma Layoffs Hit California, Massachusetts Hard
During the first quarter, 22 rounds of biopharma layoffs in California affected about 995 employees total, while 17 rounds in Massachusetts impacted around 410 people, based on
BioSpace
estimates. Meanwhile, competition for jobs in those states increased year over year, according to
BioSpace
data.
April 17, 2025
·
5 min read
·
Angela Gabriel
Job Trends
Biopharma Employees’ Confidence in Employers Dips Month-Over-Month in February
Biopharma employees reporting a positive business outlook for their companies dropped month over month but increased year over year in February, according to the Glassdoor Employee Confidence Index. Glassdoor’s findings align with recent
BioSpace
data.
March 27, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Avirmax Biopharma Inc. to Present at the 2025 ARVO Annual Meeting in Salt Lake City
April 23, 2025
·
2 min read
Policy
Trump’s Whiplash Tariffs and HHS Layoffs Set Biopharma Industry Ablaze
As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, regulators and many others speak out.
April 11, 2025
·
3 min read
·
BioSpace Editorial Staff
Press Releases
Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17
April 14, 2025
·
3 min read
Editorial
Biopharma Professionals Know All Too Well What Laid-Off HHS Employees Are Experiencing
Health and Human Services employees aren’t the only ones out of work. Thousands of private-sector biopharma professionals lost their jobs in the first quarter.
April 11, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering
April 4, 2025
·
4 min read
1 of 70,963
Next
